Ockenheim, Germany

Sven Luttke

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Kg. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sven Luttke. Retrieved from https://idiyas.com/inventor/sven-luttke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Sven Luttke

Introduction: Sven Luttke is a distinguished inventor based in Ockenheim, Germany, known for his significant contributions to the field of chemistry. With a focus on pharmaceutical innovations, he has earned recognition for his pioneering work in the preparation of xanthine derivatives.

Latest Patents: Sven Luttke holds one patent, titled "Process for preparing xanthine derivatives, in particular." This innovation showcases his expertise in developing effective methodologies for creating compounds with potential therapeutic applications, particularly in the field of medicine.

Career Highlights: Luttke is currently employed at Boehringer Ingelheim KG, a leading global pharmaceutical company. His role within the organization has allowed him to collaborate with top minds in the industry, affirming his standing as a key contributor to innovative chemical processes.

Collaborations: Throughout his career, Sven has collaborated with numerous professionals, including his coworker Ulrike Kufner-Muhl. Their partnership reflects a shared commitment to advancing research and developing new solutions in the pharmaceutical domain.

Conclusion: Sven Luttke exemplifies the spirit of innovation within the pharmaceutical sector. His patent work on xanthine derivatives not only highlights his inventiveness but also underscores the importance of collaborative efforts in achieving breakthroughs that can positively impact healthcare and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…